Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The Viral Hepatitis National Strategic Plan for the United States, released by HHS, offers a road map for the next five years.
Premature discontinuation of hepatitis C treatment did not diminish the likelihood of sustained virological response.
The hep C mortality reduction goal will not be met by any state, according to recent projections.
Despite new guidelines, too few infants born to mothers with hepatitis C were screened for the virus.
Areas with lower population density have not seen the same slowdown as urban areas.
Researchers found that longer usage of injection drugs was positively linked to hep C testing.
Requiring sobriety prior to treatment and curtailing harm reduction hinder efforts to eliminate hep C.
The blood-borne virus, which can lead to cirrhosis and liver cancer, remains a major global health threat.
The Arlington location is one of over 35 clinics in the South operated by CAN Community Health.
Some state Medicaid programs and prison systems still restrict treatment based on substance use or stage of liver disease.
Readily available clinical parameters can identify those at greatest risk for hepatocellular carcinoma.
A recent study in Boston found that only 6% of people at detox centers who tested positive for either virus received follow-up medical care.
Only three states are expected to meet the 2030 goal.
A revamped National Harm Reduction Coalition tackles the “racist war on drugs” and advocates for people who use drugs.
We’re asking 4,000 people to stand up and be counted in quest to raise awareness of viral hepatitis.
Aimed at reducing the high incidence of HCV infection in black communities by drawing attention to this neglected health disparity
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.